For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Other comprehensive income (gain) | - | -7 | -176 | 979 |
| Revenue | 141,249 | 140,500 | 134,269 | 136,139 |
| Cost of revenue | 31,938 | 35,163 | 32,937 | 34,657 |
| Gross profit | 109,311 | 105,337 | 101,332 | 101,482 |
| Research and development expenses | 24,235 | 24,505 | 22,892 | 29,284 |
| Selling, general and administrative expenses | 84,550 | 78,341 | 78,232 | 78,390 |
| Total operating expenses | 108,785 | 102,846 | 101,124 | 107,674 |
| Income (gain) from operations | 526 | 2,491 | 208 | -6,192 |
| Interest expense | 1,340 | 1,504 | 1,468 | 1,490 |
| Interest income | 1,245 | 1,331 | 1,165 | 941 |
| Loss on debt extinguishment | - | 0 | 0 | 0 |
| Other expense | -37 | 42 | 9 | 812 |
| Income (gain) before income tax expense | 394 | 2,360 | -86 | -5,929 |
| Income tax expense | 286 | 604 | 181 | 261 |
| Net income (gain) | 108 | 1,756 | -267 | -6,190 |
| Unrealized gain on investments | - | 0 | 0 | 0 |
| Foreign currency translation adjustment | -339 | -7 | -176 | 979 |
| Comprehensive gain, net of tax | -231 | 1,749 | -443 | -5,211 |
| Basic EPS | 0 | 0.036 | -0.01 | -0.13 |
| Diluted EPS | 0 | 0.036 | -0.01 | -0.13 |
| Basic Average Shares | 48,334,000 | 47,966,000 | 47,920,000 | 47,721,000 |
| Diluted Average Shares | 49,046,000 | 47,966,000 | 47,920,000 | 47,721,000 |
AtriCure, Inc. (ATRC)
AtriCure, Inc. (ATRC)